NOVARTIS AG-SPONSORED ADR (NVS) Stock Cash Flow
NYSE:NVS - New York Stock Exchange, Inc. - US66987V1098 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 12.86B | 11.94B | 8.57B | 6.96B | 24.02B | |||
| Depreciation Amortization | 5.91B | 4.60B | 8.28B | 7.18B | 6.11B | |||
| Change In Working Capital | -4.20B | -4.44B | -4.79B | -4.30B | -3.35B | |||
| Interest Paid | 940.00M | 855.00M | 751.00M | 696.00M | 664.00M | |||
| Taxes Paid | 2.22B | 2.26B | 2.79B | 1.98B | 2.34B | |||
| Other non cash items | 4.43B | 5.52B | 2.40B | 4.40B | -11.71B | |||
| OPERATING CASH FLOW | 19.00B | 17.62B | 14.46B | 14.24B | 15.07B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.15B | -3.81B | -2.75B | -2.67B | -2.97B | |||
| Other Investing Activity | -2.13B | -3.70B | 8.35B | 4.14B | 7.18B | |||
| INVESTING CASH FLOW | -6.28B | -7.51B | 5.60B | 1.47B | 4.21B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.71B | 4.39B | -1.94B | -2.56B | -5.99B | |||
| Stock Issued/Repurchased | -9.92B | -8.30B | -8.57B | -10.55B | -3.00B | |||
| Dividend Paid | -7.75B | -7.62B | -7.25B | -7.51B | -7.37B | |||
| Other Financing Activity | -173.00M | -207.00M | 3.48B | 55.00M | 94.00M | |||
| FINANCING CASH FLOW | -15.13B | -11.74B | -14.28B | -20.56B | -16.26B | |||
| Exchange Rate Effect | 8.00M | -298.00M | 100.00M | -32.00M | -266.00M | |||
| CHANGE IN CASH | -2.40B | -1.93B | 5.88B | -4.89B | 2.75B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 19.00B | 17.62B | 14.46B | 14.24B | 15.07B | |||
| Capital Expenditure | -4.15B | -3.81B | -2.75B | -2.67B | -2.97B | |||
| FREE CASH FLOW | 14.85B | 13.80B | 11.71B | 11.56B | 12.10B | |||
All data in USD